Correlation Between 4D Molecular and Biohaven Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Biohaven Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Biohaven Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Biohaven Pharmaceutical Holding, you can compare the effects of market volatilities on 4D Molecular and Biohaven Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Biohaven Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Biohaven Pharmaceutical.
Diversification Opportunities for 4D Molecular and Biohaven Pharmaceutical
-0.86 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between FDMT and Biohaven is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Biohaven Pharmaceutical Holdin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biohaven Pharmaceutical and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Biohaven Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biohaven Pharmaceutical has no effect on the direction of 4D Molecular i.e., 4D Molecular and Biohaven Pharmaceutical go up and down completely randomly.
Pair Corralation between 4D Molecular and Biohaven Pharmaceutical
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Biohaven Pharmaceutical. In addition to that, 4D Molecular is 1.66 times more volatile than Biohaven Pharmaceutical Holding. It trades about -0.13 of its total potential returns per unit of risk. Biohaven Pharmaceutical Holding is currently generating about 0.08 per unit of volatility. If you would invest 3,459 in Biohaven Pharmaceutical Holding on September 1, 2024 and sell it today you would earn a total of 1,142 from holding Biohaven Pharmaceutical Holding or generate 33.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Biohaven Pharmaceutical Holdin
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Biohaven Pharmaceutical |
4D Molecular and Biohaven Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Biohaven Pharmaceutical
The main advantage of trading using opposite 4D Molecular and Biohaven Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Biohaven Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biohaven Pharmaceutical will offset losses from the drop in Biohaven Pharmaceutical's long position.| 4D Molecular vs. Tff Pharmaceuticals | 4D Molecular vs. Eliem Therapeutics | 4D Molecular vs. Inhibrx | 4D Molecular vs. Enliven Therapeutics |
| Biohaven Pharmaceutical vs. Immunome | Biohaven Pharmaceutical vs. Inhibrx | Biohaven Pharmaceutical vs. Day One Biopharmaceuticals | Biohaven Pharmaceutical vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |